The start of the 2025-26 early signing period begins Wednesday. See where Observer-area prep athletes will play next.

Both Colgate University Raiders lacrosse programs are entering the 2026 season with fresh energy, deep rosters and a shared ...

Farrell scored two goals as second-seeded Sayville secured the Suffolk Class A championship with a 3-2 victory over ...

Marriotts Ridge senior Abbi Livay stood confidently on the Mustangs’ track Oct. 15 with her red hair flowing in the wind. Livay’s hair has always been a key part of her personality. Her grandmother ...

Story Links BALTIMORE, MD – Johns Hopkins men's lacrosse coach Peter Milliman recently announced the addition of Braden Wallace as the program's Operations. Wallace ...

Some Johns Hopkins University students raised safety concerns after a repeat offender was arrested for an alleged assault and attempted rape on the Baltimore campus. Trump spent 90 minutes with ‘60 ...

Johns Hopkins scientists uncovered microscopic “nanotube” channels that neurons use to transfer toxic molecules. While this process clears waste, it can also spread harmful proteins like amyloid-beta.

Johns Hopkins—the largest private employer in Maryland—delivered a $40 billion economic impact across the state last year, including supporting 149,000 jobs, according to a new analysis. In Baltimore ...

The 2026 face-off specialist will join Coach Marty Ward’s rising Florida Southern lacrosse program, aiming to help the Moccasins reach new postseason heights. Calvert Hall face-off specialist Nick ...

Hahrie Han, a political scientist at Johns Hopkins University and inaugural director of the university's SNF Agora Institute, has been named one of 22 recipients of a 2025 MacArthur Fellowship, among ...

Baltimore-based Johns Hopkins University launched a national drug supply chain dashboard in June 2025 to track production data, shortage history and vulnerability risks across more than 60,000 drugs.

On September 18 and 19, 2025, the Patent Trial and Appeals Board (“PTAB”) issued final written decisions for four inter partes review (“IPR”) challenges brought by Merck Sharp & Dohme LLC (“Merck”) ...